Abstract
Aim
To assess volume changes of treated and non-treated liver segments after selective internal radiation therapy (SIRT) in patients with hepatocellular carcinoma (HCC) and compromised hepatic function due to cirrhosis over a time course of 12 months after SIRT.Materials and methods
All patients underwent SIRT of the right liver lobe with yttrium 90 (Y-90). Absolute volumes of the right liver lobe (RLV) and left liver lobe (LLV) were assessed using computed tomography (CT) before and 1, 3, 6, 9, and 12 months after SIRT. Changes at follow-up relative to baseline volumes were analysed ("normalized" volumes). Furthermore, the relative volume of the LLV [LLV/(RLV + LLV)] was calculated ("relative" volumes). For statistical analysis p < 0.05 was considered statistically significant.Results
Forty-five HCC patients (36 men, nine women, mean age 71.9 years, range 55-90 years) were studied. The mean baseline RLV and LLV reached 1116 ml [95% confidence intervals (CI): 1006-1226 ml] and 601 ml (95% CI: 514-688 ml), respectively. At 6 months following radioembolization, the LLV increased by 30.8% (RLV -33.9%), with the relative LLV increasing from 35% (pre-radioembolization) to 50.5%. RLV further decreased and LLV increased 12 months after SIRT (nRLV -44.9%, nLLV +40.1%, relative LLV 56.5%). All changes were significant.Conclusion
Constraints of liver function after radioembolization of one liver lobe can be partially compensated through hypertrophy of the contralateral lobe. The rate of volumetric changes is the highest in the first 6 months following radioembolization. The present data can also be the basis to propagate radiation lobectomy for selected patients, simultaneously providing tumour control and future remnant liver hypertrophy before curative hemihepatectomy.References
Articles referenced by this article (24)
Radioembolization of liver tumors with yttrium-90 microspheres.
Semin Nucl Med, (2):105-121 2010
MED: 20113679
Yttrium-90 microspheres for the treatment of hepatocellular carcinoma
Gastroenterology, (Suppl. 1):S194- 2004
Radioembolization with 90Y microspheres: angiographic and technical considerations.
Cardiovasc Intervent Radiol, (4):571-592 2007
MED: 17516113
Radioembolization of symptomatic, unresectable neuroendocrine hepatic metastases using yttrium-90 microspheres.
Cardiovasc Intervent Radiol, (2):334-342 2011
MED: 21847708
Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes.
Gastroenterology, (1):52-64 2009
MED: 19766639
The role of tumor vascularity in predicting survival after yttrium-90 radioembolization for liver metastases.
J Vasc Interv Radiol, (12):1564-1569 2009
MED: 19846320
Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival.
Hepatology, (5):1741-1749 2010
MED: 21038413
Hepatobiliary effects of 90yttrium microsphere therapy for unresectable hepatocellular carcinoma.
Hum Pathol, (1):125-134 2008
MED: 18799190
Fibrosis, portal hypertension, and hepatic volume changes induced by intra-arterial radiotherapy with 90yttrium microspheres.
Dig Dis Sci, (9):2556-2563 2008
MED: 18231857
Liver regeneration and the atrophy-hypertrophy complex.
Semin Intervent Radiol, (2):92-103 2008
MED: 21326550
Show 10 more references (10 of 24)
Citations & impact
Impact metrics
Citations of article over time
Alternative metrics
Smart citations by scite.ai
Explore citation contexts and check if this article has been
supported or disputed.
https://scite.ai/reports/10.1016/j.crad.2013.09.009
Article citations
Anatomical Quantitative Volumetric Evaluation of Liver Segments in Hepatocellular Carcinoma Patients Treated with Selective Internal Radiation Therapy: Key Parameters Influencing Untreated Liver Hypertrophy.
Cancers (Basel), 16(3):586, 30 Jan 2024
Cited by: 0 articles | PMID: 38339337 | PMCID: PMC10854872
Automated MRI liver segmentation for anatomical segmentation, liver volumetry, and the extraction of radiomics.
Eur Radiol, 34(8):5056-5065, 13 Jan 2024
Cited by: 2 articles | PMID: 38217704 | PMCID: PMC11245591
Contemporary applications of Y90 for the treatment of hepatocellular carcinoma.
Hepatol Commun, 7(10):e0288, 02 Oct 2023
Cited by: 5 articles | PMID: 37782464 | PMCID: PMC10545406
Portal hypertension increases the risk of hepatic decompensation after 90Yttrium radioembolization in patients with hepatocellular carcinoma: a cohort study.
Therap Adv Gastroenterol, 16:17562848231206995, 31 Oct 2023
Cited by: 0 articles | PMID: 37920686 | PMCID: PMC10619355
Dose finding study for unilobar radioembolization using holmium-166 microspheres to improve resectability in patients with HCC: the RALLY protocol.
BMC Cancer, 23(1):771, 18 Aug 2023
Cited by: 0 articles | PMID: 37596578 | PMCID: PMC10436405
Go to all (44) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.